Among 21 analysts covering Molina Healthcare (NYSE:MOH), 7 have Buy rating, 3 Sell and 11 Hold. Therefore 33% are positive. Molina Healthcare had 54 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Wednesday, June 7 by Jefferies. Jefferies downgraded the stock to “Hold” rating in Thursday, December 15 report. The rating was downgraded by Credit Suisse to “Underperform” on Friday, November 11. Morgan Stanley maintained it with “Overweight” rating and $89 target in Friday, November 3 report. The company was upgraded on Friday, July 31 by Stifel Nicolaus. The firm has “Equal Weight” rating given on Monday, November 2 by Barclays Capital. The stock of Molina Healthcare, Inc. (NYSE:MOH) earned “Buy” rating by J.P. Morgan on Tuesday, January 16. The company was maintained on Tuesday, March 21 by Barclays Capital. The firm has “Hold” rating by Jefferies given on Wednesday, February 14. The firm has “Market Perform” rating given on Wednesday, February 14 by BMO Capital Markets. See Molina Healthcare, Inc. (NYSE:MOH) latest ratings:

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 61 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was upgraded by Goldman Sachs on Tuesday, December 8 to “Americas Conviction Buy List”. The firm has “Hold” rating given on Friday, October 20 by Jefferies. Evercore initiated the stock with “Buy” rating in Wednesday, January 3 report. The company was maintained on Wednesday, January 31 by Cowen & Co. The firm earned “Hold” rating on Thursday, July 13 by Jefferies. As per Monday, December 4, the company rating was maintained by Leerink Swann. As per Monday, January 11, the company rating was maintained by Stifel Nicolaus. Mizuho maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Friday, May 27. Mizuho has “Buy” rating and $170 target. The firm earned “Buy” rating on Monday, October 2 by Robert W. Baird. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Tuesday, August 22 by Jefferies.

Since August 17, 2017, it had 0 insider buys, and 8 sales for $21.15 million activity. $366,645 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by Shine Daniel P. HARRIS C MARTIN sold $65,149 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, August 30. $1.05 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by Williamson Stephen on Wednesday, February 7. HORNSTRA PETER E also sold $721,091 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Tuesday, September 5. The insider CASPER MARC N sold 50,000 shares worth $9.59M. On Thursday, August 17 the insider MANZI JIM P sold $1.96 million. Herrema Gregory J. also sold $7.32 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Friday, February 2.

Since August 17, 2017, it had 0 insider buys, and 25 selling transactions for $47.42 million activity. The insider ORLANDO STEVEN J sold $60,000. Shares for $1.02M were sold by MOLINA J MARIO MD on Tuesday, October 3. MOLINA JOHN C sold 19,885 shares worth $1.50M. Barlow Jeff D. had sold 5,224 shares worth $352,098 on Monday, October 9. Another trade for 45,000 shares valued at $4.14 million was made by DENTINO WILLIAM on Wednesday, January 17. $324,293 worth of Molina Healthcare, Inc. (NYSE:MOH) was sold by Rubino Lisa A. $16,260 worth of Molina Healthcare, Inc. (NYSE:MOH) was sold by ROMNEY RONNA.